Press Release Celdara Medical, LLC today announced that the National Institute of Allergy and Infectious Disease of the National Institutes of Health (NIH) has awarded a three-year Small Business Innovation Research (SBIR) Fast-Track award to fund the company’s advancement of CM-IAV1, a human monoclonal antibody to treat and prevent both […]
Celdara Medical Receives $2.3M SBIR to Advance Global Preparedness for an Influenza Pandemic
Continue Reading